# Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)

> **NCT00474799** · PHASE1 · COMPLETED · sponsor: **Javelin Pharmaceuticals** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MNS075

## Key facts

- **NCT ID:** NCT00474799
- **Lead sponsor:** Javelin Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2008-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00474799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00474799, "Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00474799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*